OLANZAPINE
Generic: OLANZAPINE
Macleods Pharmaceuticals LimitedManufacturer
ORALRoute
OLANZAPINEActive Substance
2014-08-15Original Approval
OLANZAPINE is FDA application ANDA202862, sponsored by MACLEODS PHARMS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-02-16
Olanzapine Tablets, USP 10 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA , Inc. Plainsboro, NJ 08cGmp Deviations
Class III2016-10-13
Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, BachFailed impurities/degradation specifications: due to out-of-specification result for the Related Sub
Class III2026-08-27
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Class II2024-11-25
Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 0854Failed Impurities/Degradation Specifications
Top Reported Reactions
1
DRUG INEFFECTIVE
6,018 reports
2
OFF LABEL USE
4,342 reports
3
TOXICITY TO VARIOUS AGENTS
4,067 reports
4
DRUG INTERACTION
3,445 reports
5
WEIGHT INCREASED
2,864 reports
6
NAUSEA
2,802 reports
7
SOMNOLENCE
2,776 reports
8
CONDITION AGGRAVATED
2,405 reports
9
FATIGUE
2,383 reports
10
VOMITING
2,383 reports